Cargando…

Directed Evolution of a Mycobacteriophage

Bacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cebriá-Mendoza, María, Sanjuán, Rafael, Domingo-Calap, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627502/
https://www.ncbi.nlm.nih.gov/pubmed/31027152
http://dx.doi.org/10.3390/antibiotics8020046
_version_ 1783434753506017280
author Cebriá-Mendoza, María
Sanjuán, Rafael
Domingo-Calap, Pilar
author_facet Cebriá-Mendoza, María
Sanjuán, Rafael
Domingo-Calap, Pilar
author_sort Cebriá-Mendoza, María
collection PubMed
description Bacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model, Mycobacterium smegmatis, here we have set up a basic methodology for mycobacteriophage growth and we have explored directed evolution as a tool for increasing phage infectivity and lytic activity. We demonstrate mycobacteriophage adaptation to its host under different conditions. Directed evolution could be used for the development of future phage therapy applications against mycobacteria.
format Online
Article
Text
id pubmed-6627502
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66275022019-07-23 Directed Evolution of a Mycobacteriophage Cebriá-Mendoza, María Sanjuán, Rafael Domingo-Calap, Pilar Antibiotics (Basel) Article Bacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model, Mycobacterium smegmatis, here we have set up a basic methodology for mycobacteriophage growth and we have explored directed evolution as a tool for increasing phage infectivity and lytic activity. We demonstrate mycobacteriophage adaptation to its host under different conditions. Directed evolution could be used for the development of future phage therapy applications against mycobacteria. MDPI 2019-04-25 /pmc/articles/PMC6627502/ /pubmed/31027152 http://dx.doi.org/10.3390/antibiotics8020046 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cebriá-Mendoza, María
Sanjuán, Rafael
Domingo-Calap, Pilar
Directed Evolution of a Mycobacteriophage
title Directed Evolution of a Mycobacteriophage
title_full Directed Evolution of a Mycobacteriophage
title_fullStr Directed Evolution of a Mycobacteriophage
title_full_unstemmed Directed Evolution of a Mycobacteriophage
title_short Directed Evolution of a Mycobacteriophage
title_sort directed evolution of a mycobacteriophage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627502/
https://www.ncbi.nlm.nih.gov/pubmed/31027152
http://dx.doi.org/10.3390/antibiotics8020046
work_keys_str_mv AT cebriamendozamaria directedevolutionofamycobacteriophage
AT sanjuanrafael directedevolutionofamycobacteriophage
AT domingocalappilar directedevolutionofamycobacteriophage